| Model Number |
1103 |
| Medical Device Problem Code |
Adverse Event Without Identified Device or Use Problem (2993)
|
| Health Effect - Clinical Codes |
Bacterial Infection (1735); Cardiomyopathy (1764); Unspecified Infection (1930); Sepsis (2067); Multiple Organ Dysfunction Syndrome (3261); Bacteremia (4846)
|
| Date of Event |
12/22/2025
|
|
Type of Reportable Event
|
Serious Injury
|
|
Additional Manufacturer Narrative
|
|
Investigation of this event is pending and a supplemental report will be sent upon its completion.Continuation of d10: 693565 & 2088tc & 1258t leads implant date: (b)(6) 2013.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was reported that a patient with a ventricular assist device (vad) experienced multiple system organ failure (msof) and sepsis from an unknown source of infection.It was noted that the patient had not wanted to live for a long time but did not believe in stopping the vad; so, when the patient got septic and had msof, treatment was declined.The patient entered hospice care, and the vad was turned off.The patient subsequently expired.
|
| |
|
Additional Manufacturer Narrative
|
|
A supplemental report is being submitted for additional information received.Updated b5 and h6.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Event or Problem Description
|
|
It was further reported that the patient had methicillin-resistant staphylococcus aureus (mrsa) bacteremia, driveline infection as well as end stage ischemic cardiomyopathy.
|
| |
|
Additional Manufacturer Narrative
|
|
A supplemental report is being submitted for investigation completion.Product event summary: the ventricular assist device (vad) (b)(6) was not returned for evaluation.This complaint is associated with a clinical adverse event.A review of the device history record was not performed as the reported event is not related to a manufacturing or servicing issue.Of note, information provided by the site indicated that the patient transitioned to hospice care, the vad was turned off, and the patient subsequently expired.Based on the available information, the device may have caused or contributed to the reported event.Per the instructions for use, driveline infection, multi-organ failure, sepsis, and death are known potential complications associated with the implantation of a vad.Based on review of past adverse events for this patient, it was noted that the patient had a history of driveline infection events.Possible clinical factors that may have contributed to this event include the patient¿s pre-existing history and related comorbidities, the progression of their underlying disease and the patient's complex post-operative course, including care of the driveline exit site.There are possible patient, pharmacological and procedural factors that may have contributed to this event.Investigation of this event is completed and the file will be closed.If new information is received, the file will be re-opened and a supplemental will be submitted.Medtronic submits this report to comply with fda regulations 21 cfr parts 4 and 803.Medtronic has made reasonable efforts to provide as much relevant information as is available to the company as of the submission date of this report.This report does not constitute an admission or a conclusion by fda, medtronic, or its employees that the device, medtronic, or its employee caused or contributed to the event described in the report.Any required fields that are unpopulated are blank because the information is currently unknown or unavailable.Medtronic will submit a supplemental report if additional relevant information becomes known.
|
| |
|
Search Alerts/Recalls
|